{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:23:24Z","timestamp":1747196604242,"version":"3.40.5"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Anticoagulation in atrial fibrillation (AF) increases the risk of major bleeding. No predictive model has hitherto provided estimates of the absolute risk for individual patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Aim<\/jats:title>\n<jats:p>To predict the individual 1-year risk of major bleeding in patients with AF taking anticoagulants and evaluate the importance of individual risk factors.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Design<\/jats:title>\n<jats:p>A nationwide register-based cohort study.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Participants<\/jats:title>\n<jats:p>Danish patients with first-time non-valvular AF who redeemed anticoagulants within 7 days after diagnosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Method<\/jats:title>\n<jats:p>The individual absolute risk of major bleeding was estimated from a logistic regression model (the Calculator of Absolute Bleeding Risk\/CABS model) utilising the same risk factors as HAS-BLED, except allowing non-linear age effects, and allowing effect modification of all factors according to history of bleeding. The logistic regression was assessed in term of discrimination using the Area Under the ROC curve (AUC) and calibration.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec006\">\n<jats:title>Results<\/jats:title>\n<jats:p>Among 76,102 patients with AF redeeming anticoagulants, 2,406 suffered a major bleeding within 1 year. History of bleeding was the strongest predictor, and age significantly modified the risk. The CABS model superseded HAS-BLED score with regards to discrimination (AUC 0.646 vs 0.615, p&lt;0.001) and calibrated well. A typical male patient was 70-years old without any risk factors and he had a 1-year bleeding risk of 1.4% (1.2; 1.6) while a typical female patient was 73-years old, had hypertension and a 1-year bleeding risk of 2.2% (1.9;2.6).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec007\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>We propose CABS as a tool for prediction of individual absolute risks of major bleeding in patients with AF taking anticoagulant. The predicted absolute risk can be used for patient counselling.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0312294","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T18:40:21Z","timestamp":1731609621000},"page":"e0312294","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Individualised prediction of major bleeding in patients with atrial fibrillation treated with anticoagulation"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6029-255X","authenticated-orcid":true,"given":"Anne Pernille","family":"Toft-Petersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"J.-Y. Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brice","family":"Ozenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Alexander","family":"Gerds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2892-6131","authenticated-orcid":true,"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"pone.0312294.ref001","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/13814788.2013.852535","article-title":"Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: Cross-sectional population database study","volume":"20","author":"T Dreischulte","year":"2014","journal-title":"European Journal of General Practice"},{"key":"pone.0312294.ref002","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/heartjnl-2012-303472","article-title":"The use of anticoagulants in the management of atrial fibrillation among general practices in England","volume":"99","author":"C Cowan","year":"2013","journal-title":"Heart"},{"key":"pone.0312294.ref003","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.amjmed.2016.11.001","article-title":"Absence of Oral Anticoagulation and Subsequent Outcomes Among Outpatients with Atrial Fibrillation","volume":"130","author":"PL Hess","year":"2017","journal-title":"Am J Med"},{"key":"pone.0312294.ref004","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/MAJ.0000000000000349","article-title":"Physician\u2019s fear of anticoagulant therapy in nonvalvular atrial fibrillation","volume":"348","author":"S Sen","year":"2014","journal-title":"Am J Med Sci"},{"key":"pone.0312294.ref005","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"130","author":"CT January","year":"2014","journal-title":"Circulation"},{"key":"pone.0312294.ref006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"42","author":"G Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"pone.0312294.ref007","doi-asserted-by":"crossref","first-page":"e003839","DOI":"10.1136\/bmjopen-2013-003839","article-title":"Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes","volume":"4","author":"AM Gallagher","year":"2014","journal-title":"BMJ Open"},{"key":"pone.0312294.ref008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCULATIONAHA.114.012061","article-title":"Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation","volume":"131","author":"DJ Graham","year":"2015","journal-title":"Circulation"},{"key":"pone.0312294.ref009","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/j.1538-7836.2011.04378.x","article-title":"Bleeding risk in \u201creal world\u201d patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort","volume":"9","author":"JB Olesen","year":"2011","journal-title":"J Thromb Haemost"},{"key":"pone.0312294.ref010","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1160\/TH11-05-0364","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a \u2018real world\u2019 nationwide cohort study.","volume":"106","author":"JB Olesen","year":"2011","journal-title":"Thromb Haemost"},{"key":"pone.0312294.ref011","first-page":"3258","article-title":"The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation","volume":"36","author":"EC O\u2019Brien","year":"2015","journal-title":"Eur Heart J"},{"key":"pone.0312294.ref012","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2017.07.043","article-title":"Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making","volume":"245","author":"PA Noseworthy","year":"2017","journal-title":"Int J Cardiol"},{"key":"pone.0312294.ref013","first-page":"1","article-title":"Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study","author":"T Forslund","year":"2017","journal-title":"EP Europace"},{"key":"pone.0312294.ref014","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach","volume":"137","author":"GYH Lip","year":"2010","journal-title":"Chest"},{"key":"pone.0312294.ref015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.thromres.2005.08.007","article-title":"Stroke prevention with aspirin, warfarin and ximelagatran in patients with non-valvular atrial fibrillation: A systematic review and meta-analysis","volume":"118","author":"GYH Lip","year":"2006","journal-title":"Thromb Res"},{"key":"pone.0312294.ref016","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.amjcard.2017.06.058","article-title":"Bleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism","volume":"120","author":"H Zulkifly","year":"2017","journal-title":"Am J Cardiol"},{"key":"pone.0312294.ref017","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"key":"pone.0312294.ref018","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"MC Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"pone.0312294.ref019","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ahj.2005.04.017","article-title":"Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).","volume":"151","author":"BF Gage","year":"2006","journal-title":"Am Heart J"},{"key":"pone.0312294.ref020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/clc.22435","article-title":"The HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysis.","volume":"38","author":"W Zhu","year":"2015","journal-title":"Clin Cardiol"},{"key":"pone.0312294.ref021","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.amjcard.2017.07.051","article-title":"Comparison of the CHA 2 DS 2 -VASc, CHADS 2, HAS-BLED, ORBIT, and ATRIA Risk Scores in Predicting Non\u2013Vitamin K Antagonist Oral Anticoagulants-Associated Bleeding in Patients With Atrial Fibrillation","volume":"120","author":"X Yao","year":"2017","journal-title":"Am J Cardiol"},{"key":"pone.0312294.ref022","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"M Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"pone.0312294.ref023","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential.","volume":"7","author":"M Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"pone.0312294.ref024","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1403494810394717","article-title":"The Danish National Prescription Registry.","volume":"39","author":"HW Kildemoes","year":"2011","journal-title":"Scand J Public Health"},{"key":"pone.0312294.ref025","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/jth.15048","article-title":"Definition of major bleeding: Prognostic classification","volume":"18","author":"L Franco","year":"2020","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"pone.0312294.ref026","first-page":"6","article-title":"Major Bleeding Complications and Persistence With Oral Anticoagulation in Non-Valvular Atrial Fibrillation: Contemporary Findings in Real-Life Danish Patients.","author":"M Lamberts","year":"2017","journal-title":"J Am Heart Assoc"},{"year":"2001","author":"FE Harrell","key":"pone.0312294.ref027"},{"key":"pone.0312294.ref028","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jamia\/ocz228","article-title":"A tutorial on calibration measurements and calibration models for clinical prediction models","volume":"27","author":"Y Huang","year":"2020","journal-title":"Journal of the American Medical Informatics Association"},{"volume-title":"R: A language and environment for statistical computing","year":"2020","author":"R Core Team","key":"pone.0312294.ref029"},{"key":"pone.0312294.ref030","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2147\/CLEP.S423587","article-title":"The Danish National Child Health Register","volume":"15","author":"MP Andersen","year":"2023","journal-title":"Clin Epidemiol"},{"key":"pone.0312294.ref031","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"L Friberg","year":"2012","journal-title":"Circulation"},{"key":"pone.0312294.ref032","first-page":"3","article-title":"Real\u2010world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non\u2010valvular atrial fibrillation patients in England.","author":"A Bakhai","year":"2020","journal-title":"J Eval Clin Pract"},{"key":"pone.0312294.ref033","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/clc.22133","article-title":"Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey","volume":"36","author":"A Brandes","year":"2013","journal-title":"Clin Cardiol"},{"key":"pone.0312294.ref034","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.amjcard.2016.06.014","article-title":"How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?","volume":"118","author":"GR Quinn","year":"2016","journal-title":"Am J Cardiol"},{"key":"pone.0312294.ref035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jacep.2017.04.024","article-title":"Patients With Atrial Fibrillation Who Are Not on Anticoagulant Treatment Due to Increased Bleeding Risk Are Common and Have a High Risk of Stroke.","volume":"3","author":"B Redfors","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"pone.0312294.ref036","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/jth.13386","article-title":"Bleeding risk assessment in atrial fibrillation: observations on the use and misuse of bleeding risk scores","volume":"14","author":"GYH Lip","year":"2016","journal-title":"J Thromb Haemost"},{"key":"pone.0312294.ref037","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/heartjnl-2021-319702","article-title":"Novel bleeding prediction model in atrial fibrillation patients on new oral anticoagulants","volume":"108","author":"O Barnett-Griness","year":"2022","journal-title":"Heart"},{"key":"pone.0312294.ref038","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/23969873211008770","article-title":"Trends in incidence of oral anticoagulant-related intracerebral hemorrhage and sales of oral anticoagulants in Capital Region of Denmark 2010\u20132017","volume":"6","author":"J Grundtvig","year":"2021","journal-title":"Eur Stroke J"},{"key":"pone.0312294.ref039","doi-asserted-by":"crossref","first-page":"e13285","DOI":"10.1111\/ijcp.13285","article-title":"The safety of NOACs in atrial fibrillation patient subgroups: A narrative review","volume":"73","author":"GYH Lip","year":"2019","journal-title":"Int J Clin Pract"},{"key":"pone.0312294.ref040","doi-asserted-by":"crossref","first-page":"ii13","DOI":"10.1093\/ndt\/gfw465","article-title":"Relative risk versus absolute risk: one cannot be interpreted without the other.","volume":"32","author":"M Noordzij","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"pone.0312294.ref041","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ejheart.2008.05.006","article-title":"Accuracy of a heart failure diagnosis in administrative registers","volume":"10","author":"T K\u00fcmler","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"pone.0312294.ref042","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2016.02.023","article-title":"Antithrombotic therapy in patients with non-valvular atrial fibrillation in Southern Sweden: A population-based cohort study","volume":"140","author":"N Mochalina","year":"2016","journal-title":"Thromb Res"},{"key":"pone.0312294.ref043","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/jgs.14688","article-title":"Use of Oral Anticoagulant Therapy in Older Adults with Atrial Fibrillation After Acute Ischemic Stroke.","volume":"65","author":"ER McGrath","year":"2017","journal-title":"J Am Geriatr Soc"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T18:40:36Z","timestamp":1731609636000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0312294"}},"subtitle":[],"editor":[{"given":"Mohammed","family":"Mustapha","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0312294","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}